Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISLB 2022 | Using machine learning to enhance liquid biopsy

Adam Widman • 19 Oct 2022
ISLB 2022
General

Adam Widman, MD, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses how machine learning can be utilised to analyse liquid biopsy samples and improve our understanding of the molecular processes underpinning cancer development. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Adam Widman

1:16
Potential of liquid biopsy as a monitoring tool
Adam Widman • 19 Oct 2022
1:36
Potential of machine learning in liquid biopsy
Adam Widman • 19 Oct 2022

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals